Revolution Medicines outlines $1.6B–$1.7B 2026 operating expenses as RAS(ON) inhibitor trials expand
Feb 25, 2026, 9:18 PM ETRevolution Medicines, Inc. (RVMD) Stock, RVMDW StockAI-Generated Earnings Calls Insights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results